2023
DOI: 10.1186/s12985-023-02049-4
|View full text |Cite
|
Sign up to set email alerts
|

The interactions between PML nuclear bodies and small and medium size DNA viruses

Abstract: Promyelocytic leukemia nuclear bodies (PM NBs), often referred to as membraneless organelles, are dynamic macromolecular protein complexes composed of a PML protein core and other transient or permanent components. PML NBs have been shown to play a role in a wide variety of cellular processes. This review describes in detail the diverse and complex interactions between small and medium size DNA viruses and PML NBs that have been described to date. The PML NB components that interact with small and medium size … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 208 publications
0
6
0
Order By: Relevance
“…They are also referred to as the nuclear domains 10 (ND10) based on their average number of 10 loci per nucleus in various cultured cells [ 20 ]. They are a multiprotein complex consisting of a diverse and dynamic array of both positive and negative transcription regulators known to be involved in many key cellular processes, including DNA damage response, apoptosis, autophagy, cellular differentiation, oncogenesis, epigenetic silencing, and antiviral defenses [ 18 , 19 , 21 , 22 , 23 ]. In addition to the PML-NBs’ permanent members, like PML (TRIM19), Sp100, and DAXX, various other proteins transiently reside in the PML-NBs based on cell stage, type, and condition.…”
Section: Virus Epigenetic Restriction Factors (Erfs)mentioning
confidence: 99%
See 2 more Smart Citations
“…They are also referred to as the nuclear domains 10 (ND10) based on their average number of 10 loci per nucleus in various cultured cells [ 20 ]. They are a multiprotein complex consisting of a diverse and dynamic array of both positive and negative transcription regulators known to be involved in many key cellular processes, including DNA damage response, apoptosis, autophagy, cellular differentiation, oncogenesis, epigenetic silencing, and antiviral defenses [ 18 , 19 , 21 , 22 , 23 ]. In addition to the PML-NBs’ permanent members, like PML (TRIM19), Sp100, and DAXX, various other proteins transiently reside in the PML-NBs based on cell stage, type, and condition.…”
Section: Virus Epigenetic Restriction Factors (Erfs)mentioning
confidence: 99%
“…It also recruits epigenetic modifiers such as HP1 and the histone methyltransferase EZH2 which is responsible for the deposition of H3K27me3 marks [ 25 ]. As many as 271 proteins have been reported to be associated with PML-NB under various conditions [ 22 ]. Many of these proteins have been recognized as intrinsic eRFs in diverse virus systems, but because they all colocalize with the PML-NBs, we will collectively consider them as part of the same macromolecular ND-10 complex.…”
Section: Virus Epigenetic Restriction Factors (Erfs)mentioning
confidence: 99%
See 1 more Smart Citation
“…Scientific findings show that high viral loads can be involved in the initiation or progression of human cancers [ 10 , 90 ]. Unlike viruses such as adenoviruses, which have the ability to induce the S phase of the host cell cycle to aid in the replication of their genomes, anelloviruses do not, but can replicate rapidly in their host cells [ 91 ]. Also, based on experimental findings, the presence of AVs can highlight the process of inducing cell proliferation or oncogenic space created by oncogenic viruses.…”
Section: Human Cancermentioning
confidence: 99%
“…In this review, we focus on PML bodies as important organelles in the complex system of the cell. The links between PML bodies and viruses are not detailed here as recent reviews have explored this active research field [ 6 , 7 ]. PML bodies have been extensively investigated in cancer research, especially acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL).…”
Section: Introductionmentioning
confidence: 99%